Inactive Instrument

Genetron Holdings Limited

Equities

GTH

US37186H2094

Biotechnology & Medical Research

Delayed Nasdaq Other stock markets 04:30:00 2024-03-28 pm EDT			5-day change	1st Jan Change
4.025 ^USD	+0.12%		+0.12%	+9.38%

Mar. 29	Genetron Holdings Limited(NasdaqGM:GTH) dropped from NASDAQ Composite Index	CI
Mar. 28	New Genetron Holding Limited completed the acquisition of Genetron Holdings Limited	CI

Genetron Health and IMPACT Therapeutics Announce Partnership to Drive Development of Synthetic Lethal Product Pipeline

September 27, 2021 at 06:00 am EDT

Genetron Holdings Limited announced a partnership with IMPACT Therapeutics. The two parties will cooperate together on research and development for synthetic lethal inhibitors that are based on new targets, and the development of companion diagnostic products.

Latest news about Genetron Holdings Limited

Genetron Holdings Limited(NasdaqGM:GTH) dropped from NASDAQ Composite Index	Mar. 28	CI
New Genetron Holding Limited completed the acquisition of Genetron Holdings Limited	Mar. 27	CI
ADRs End Lower; Saverone 2014 Ltd. Declines 17.7%	23-10-12	DJ
Sector Update: Health Care Stocks Steady Pre-Bell Thursday	23-10-12	MT
Sector Update: Health Care	23-10-12	MT
North American Morning Briefing : Hopes A Mild Inflation Print Will Keep Fed on Hold	23-10-12	DJ
Genetron Holdings Signs Merger Agreement to Go Private; Shares Soar Premarket	23-10-12	MT
Genetron Holdings Signs Merger Agreement to Go Private	23-10-11	MT
New Genetron Holding Limited agreed to acquire Genetron Holdings Limited for $130 million.	23-10-10	CI
Genetron Gets Nasdaq Notification Regarding Minimum Bid Price Requirement	23-05-23	MT
Genetron Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-05-12	CI
American Depositary Receipts of Asian Stocks Lower Amid Banking Sector Worries	23-03-27	MT
Genetron Holdings Regains Compliance With Nasdaq's Listing Rule	23-01-18	MT
Earlier US Stock Market Losses Weighed on Asian Equities	22-12-28	MT
Genetron Holdings Receives Non-Compliance Notice from Nasdaq	22-11-07	MT
Earnings Flash (GTH) GENETRON HOLDINGS LIMITED Reports Q2 Loss $-0.38	22-10-12	MT
Genetron Holdings Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-10-12	CI
Asian ADRs Decline in Monday Trading	22-09-26	MT
Genetron Holdings Limited(NasdaqGM:GTH) dropped from S&P Global BMI Index	22-09-19	CI
Sector Update: Health Care Stocks Decline Premarket Monday	22-08-22	MT
Genetron Gets Non-Binding Takeover Offer from CEO	22-08-22	MT
Sizhen Wang made a non binding proposal to acquire the remaining 49.2% stake in Genetron Holdings Limited from Genetron Health (Hong Kong) Company Limited and others for $60 million.	22-08-21	CI
Genetron Holdings Limited Provides Revenue Guidance for the Year 2022	22-06-02	CI
Transcript : Genetron Holdings Limited, Q1 2022 Earnings Call, Jun 02, 2022	22-06-02
Earnings Flash (GTH) GENETRON HOLDINGS LIMITED Posts Q1 Revenue $17.40M	22-06-02	MT

Chart Genetron Holdings Limited

Duration

Period

More charts

Company Profile

Genetron Holdings Limited is a precision oncology company that specializes in cancer molecular profiling and harnesses technologies in molecular biology and data science to transform cancer treatment. The Company has developed a comprehensive product and service portfolio that cover the full-cycle of cancer care from early screening, to diagnosis and treatment recommendations, to continuous monitoring and continuous care. The Company operates its businesses primarily within the China market.

Sector

Biotechnology & Medical Research

Calendar

2024-05-19 - Q1 2024 Earnings Release (Projected)

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
IQVIA HOLDINGS INC.	-1.93%	41.35B
LONZA GROUP AG	+42.15%	40.38B
MODERNA, INC.	+1.20%	39.05B
CELLTRION, INC.	-14.19%	26.67B
ICON PUBLIC LIMITED COMPANY	+1.87%	24.07B
ALNYLAM PHARMACEUTICALS, INC.	-24.66%	18.36B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-4.15%	11.68B
MEDPACE HOLDINGS, INC.	+21.22%	11.6B
UNITED THERAPEUTICS CORPORATION	+7.84%	11.15B

Other Biotechnology & Medical Research